Tech Company Inital Public Offerings

Phathom Pharmaceuticals IPO

On 10/24/2019, Phathom Pharmaceuticals became a public company.

Transaction Overview

Announced On
Transaction Type
Proceeds Purpose
We intend to use approximately $100.0 million of the net proceeds from this offering to fund the clinical development of vonoprazan and the remainder for working capital and general corporate purposes, including pre-commercial activities. We may also use a portion of the remaining net proceeds and our existing cash and cash equivalents to in-license, acquire, or invest in complementary businesses, technologies, products or assets.

Company Information

Company Status
Mailing Address
70 Willow Rd. 200
Menlo Park, CA 94025
Email Address
Phathom Pharmaceuticals (Nasdaq: PHAT), launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the clinical drug candidate vonoprazan, a novel potassium-competitive acid blocker (P-CAB).
Phathom Pharmaceuticals LinkedIn Company Profile
Social Media
Phathom Pharmaceuticals Company Twitter Account
Company News
Phathom Pharmaceuticals News
Phathom Pharmaceuticals on Facebook
Phathom Pharmaceuticals on YouTube

Management Team

Email & Social
Tadataka Yamada
  Tadataka Yamada LinkedIn Profile  Tadataka Yamada Twitter Account  Tadataka Yamada News  Tadataka Yamada on Facebook
Chief Executive Officer
David Socks
  David Socks LinkedIn Profile  David Socks Twitter Account  David Socks News  David Socks on Facebook
Chief Operating Officer
Azmi Nabulsi
  Azmi Nabulsi LinkedIn Profile  Azmi Nabulsi Twitter Account  Azmi Nabulsi News  Azmi Nabulsi on Facebook
Chief Scientific Officer
Roger Ulrich
  Roger Ulrich LinkedIn Profile  Roger Ulrich Twitter Account  Roger Ulrich News  Roger Ulrich on Facebook
VP - Bus. Development
Aditya Kohli
  Aditya Kohli LinkedIn Profile  Aditya Kohli Twitter Account  Aditya Kohli News  Aditya Kohli on Facebook



Browse more venture capital transactions:

Prev: 10/24/2019: AVIA venture capital transaction
Next: 10/24/2019: Truebill venture capital transaction


Share this article


About Our VC Transactions Data

We document every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary